LISA CASTRO: Open Payments
NPI 1245542323 · GREELEY, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,391 in 94 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $315 · 2025 $1,391
Food & beverage: $1,391
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $344 |
| Janssen Biotech, Inc. | 10 | $180 |
| Gilead Sciences, Inc. | 12 | $155 |
| Lilly USA, LLC | 7 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $100 |
| Madrigal Pharmaceuticals | 5 | $94 |
| Aimmune Therapeutics, Inc. | 5 | $79 |
| QOL Medical, LLC | 3 | $69 |
| GENZYME CORPORATION | 2 | $51 |
| Ipsen Biopharmaceuticals, Inc | 2 | $38 |
Products named: RINVOQ, TREMFYA, OMVOH, ENTYVIO, REZDIFFRA, Sucraid, SKYRIZI, DUPIXENT.
Industry payments across CO — which companies pay providers there.
